Central nervous system
Central nervous system

Central pontine myelinolysis

Definition:
Central pontine myelinolysis is a condition characterized by nerve damage caused by the destruction of the covering layer (myelin sheath) of nerve cells in the brainstem (pons).

Alternative Names:
CPM

Causes, incidence, and risk factors:

The destruction of the myelin sheath that coats nerves inhibits impulse conduction within the cell and thus decreases its ability to communicate with other cells. The most common cause of central pontine myelinolysis is a rapid, drastic change in sodium levels in the body. Most commonly, this occurs when someone is being treated for low levels of sodium (hyponatremia) and the levels rise too fast, but it can occasionally occur when high levels of sodium in the body (hypernatremia) are corrected too quickly.

This condition does not occur spontaneously; it is a complication of either treatment for other conditions or the other conditions themselves.

Risks include hyponatremia from any cause. Alcoholism, Wernicke-Korsakoff syndrome, and general ill health and malnutrition associated with serious illnesses (cachexia) increase the risk of central pontine myelinolysis.

Symptoms:
Additional symptoms that may be associated with this disease:
Signs and tests:
Examination may indicate involvement of all four extremities (spastic quadriplegia) or weakness of face, arms and legs (upper motor neuron syndromes). Reflexes may be abnormal. Eye examination may show loss of control of eye muscles, particularly cranial nerve VI paralysis (see cranial mononeuropathy VI).

A cranial MRI scan shows abnormality in the brainstem (pons). This is the primary diagnostic study.

Other procedures: This disease may also alter the results of the following tests:
Treatment:
This is an emergency disorder that requires hospitalization for initial diagnosis and treatment. There is no known cure for central pontine myelinolysis and treatment is focused on relieving symptoms.

Double vision may be reduced with the use of an eye patch.

Physical therapy may help maintain muscle strength, mobility and function in weakened arms and legs.
Expectations (prognosis):
The neurologic damage caused by central pontine myelinolysis is usually persistent. The disorder can cause serious chronic disability.
Complications:
  • Permanent neurologic losses
  • Decreased ability to work or care for self
  • Decreased ability to interact with others
Calling your health care provider:
Go to the emergency room or call the local emergency number (such as 911) if seizures, muscle weakness, or other symptoms of central pontine myelinolysis occur.
Prevention:
Gradual controlled correction of hyponatremia or hypernatremia may reduce the risk of damage to the nerves of the pons. Awareness of the side effects of several medications on sodium levels can prevent sodium levels from inadvertently being changed too quickly.

Review Date: 7/28/2002
Reviewed By: Elaine T. Kiriakopoulos, M.D., MSc, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.